Recludix Pharma
PrivateLast Round
Series B
Jan 12, 2026
Total Funding Raised
$248M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Recludix Pharma is a biotechnology company that develops innovative small-molecule inhibitors for challenging protein targets to treat cancer and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Recludix Pharma Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Recludix Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 12, 2026 | ||||
| Strategic | Jul 20, 2023 | ||||
| Series A | Nov 15, 2021 |
Key People
Founding team and executive leadership
Recludix Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Access Industries | Series A |
| Westlake Village BioPartners | Series A, Series B |
| New Enterprise Associates (NEA) | Series A |
| Alexandria Venture Investments | Series B |
| New Enterprise Associates | Series A, Series B |
| Access Biotechnology | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 16, 2026
Catherine Bovenizer promoted to Chief Financial Officer.
- Mar 16, 2026
Ajay Nirula, M.D., Ph.D. promoted to president and head of research and development.
Recludix Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Recludix Pharma's valuation, stock price, and market status.